JEFFREY JONES to Survival Analysis
This is a "connection" page, showing publications JEFFREY JONES has written about Survival Analysis.
Connection Strength
0.023
-
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16. J Natl Cancer Inst. 2006 Apr 19; 98(8):516-21.
Score: 0.012
-
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004 Oct 07; 351(15):1513-20.
Score: 0.011